CSE$GMAB

Genmab A/S · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

GMAB Q4 2023 — extraction skipped

Genmab A/S filed Form 6-K (accession 0001558370-24-004638) for Q4 2023, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.

  • Form 6-K filed; press release body not parseable here.
  • Reason: no headline numerics found by parser nor by Financial Datasets fallback.
  • Numerics rely on the Financial Datasets fallback.

Headline financials

Total Revenue

$675M

Previous: $700M-3.5%
EPS (adj)

$0.36

Previous: $0.12+200.0%

Revenue & EPS history

Genmab · Revenue · Quarterly

$675M

Q4 2023-3.5%vs Q4 2022
Beat estimate in 12 of 14 quarters(86%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+293.0%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+0.7%

Avg return

30 days after

63%

15 / 24 earnings

Positive

+6983.2%

Q4 2024

Best reaction

-8.2%

Q4 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+4.6%-2.7%-10.1%
Q3 2025+0.9%+3.8%+8.7%
Q1 2025-3.4%-6.3%+7.8%
Q4 2024+6983.2%+3.6%+2.8%
Q2 2024-0.1%-5.7%-12.8%
Q4 2023+6.8%-1.7%-3.2%
Q3 2023+7.5%+9.0%+12.2%
Q2 2023-5.5%-5.2%-3.0%
Q1 2023+6.0%+6.5%-2.7%
Q4 2022-4.8%-3.5%-4.8%
Q3 2022+8.7%+6.3%+13.7%
Q2 2022+7.3%+6.0%+6.6%
Q1 2022-3.8%-0.2%-1.9%
Q4 2021-3.6%+0.1%-16.5%
Q3 2021-4.2%-8.7%-15.6%
Q2 2021+2.6%+2.1%-3.1%
Q1 2021+4.6%+4.6%+15.1%
Q4 2020-8.2%+0.2%+9.3%
Q3 2020+14.7%+9.2%+11.8%
Q2 2020+5.9%-5.8%-4.7%
Q1 2020+7.1%+13.0%+16.3%
Q4 2019+3.9%+2.5%-20.1%
Q3 2019+1.8%+2.4%+10.0%
Q2 2019-0.1%+2.2%+0.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro